Your browser doesn't support javascript.
loading
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients.
Picchianti-Diamanti, Andrea; Aiello, Alessandra; Laganà, Bruno; Agrati, Chiara; Castilletti, Concetta; Meschi, Silvia; Farroni, Chiara; Lapa, Daniele; Najafi Fard, Saeid; Cuzzi, Gilda; Cimini, Eleonora; Grassi, Germana; Vanini, Valentina; Di Rosa, Roberta; Salemi, Simonetta; Nalli, Gabriele; Salmi, Andrea; Repele, Federica; Altera, Anna Maria Gerarda; Maffongelli, Gaetano; Palazzolo, Claudia; Vita, Serena; Leone, Sara; Puro, Vincenzo; Capobianchi, Maria Rosaria; Ippolito, Giuseppe; Nicastri, Emanuele; Goletti, Delia.
Afiliación
  • Picchianti-Diamanti A; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Aiello A; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Laganà B; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Agrati C; Laboratory of Cellular Immunology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Castilletti C; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Meschi S; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Farroni C; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Lapa D; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Najafi Fard S; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Cuzzi G; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Cimini E; Laboratory of Cellular Immunology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Grassi G; Laboratory of Cellular Immunology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Vanini V; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Di Rosa R; Unità Operativa Semplice (UOS) Professioni Sanitarie Tecniche, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Salemi S; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Nalli G; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Salmi A; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Repele F; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Altera AMG; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Maffongelli G; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Palazzolo C; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Vita S; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Leone S; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Puro V; UOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Capobianchi MR; UOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Ippolito G; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Nicastri E; Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Goletti D; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
Front Immunol ; 12: 740249, 2021.
Article en En | MEDLINE | ID: mdl-34594343

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Linfocitos T / Vacunas contra la COVID-19 / Inmunoterapia / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Linfocitos T / Vacunas contra la COVID-19 / Inmunoterapia / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Italia